PROGRAM
15. Årsmøde
Dansk Selskab for Cancerforskning
Fredag d. 03. maj 2002 |
| 08.00-08.55 |
Registrering, opsætning af posters og kaffe |
08.55-09.00
|
Velkomst ved Selskabets formand, Paul E. G. Kristjansen
Praktiske oplysninger ved Selskabets sekretær, Jørgen H. Olsen |
| SESSION I: Cancer related molecular mechanisms and epidemiology
Chairmen: Elisabeth Ralfkiær, Mads Melbye |
| 09.00-09.15 |
The Regulation of HsCdc7 throughout the Cell Cycle
Sigurd M, Bartkova J, Lukas J, Bartek J |
| 09.15-09.30 |
The role of caspases and cysteine cathepsins in apoptosis induced by tumor necrosis factor
Gyrd-Hansen M, Fehrenbacher N, Poulsen B, Boes M, Jäättelä M |
| 09.30-09.45 |
Identification of EPSTI1, a Novel Gene Induced by Epithelial-Stromal Interaction Highly Expressed in Human Breast Cancer
Nielsen HL, Rønnov-Jessen L, Petersen OW |
| 09.45-10.00 |
Hsp70 depletion induces cathepsin-mediated tumor cell death and eradicates tumor xenografts
Nylandsted J, Wick W, Fehrenbacher N, Gyrd-Hansen M, Hirt U, Brand K, Rohde M, Leist M, Weller M, Jäättelä M |
| 10.00-10.15 |
Fruits, vegetables, estrogen receptors and risk of breast cancer among postmenopausal women
Olsen A, Tjønneland A, Møller S, Overvad K |
| 10.15-10.30 |
Effects of soy isoflavanoids and fish oil on cell proliferation, apoptosis and the expression of estrogen receptor a and b in the mammary gland and colon of the rat
Kramer F, Lund E, Breinholt V, Johnson I |
| 10.30-11.00 |
POSTERS & kaffe
|
| SESSION II: EXPERIMENTAL ONCOLOGY
Chairmen: Keld Danø, Jens Overgaard
|
| 11.00-11.15 |
Identification of new therapeutic targets of colorectal cancer by microarrays
Birkenkamp-Demtroder K, Christensen LL, Olesen SH, Laiho P, Aaltonen LA, Laurberg S, Ørntoft TF |
| 11.15-11.30 |
Specific down-regulation of hypoxia-inducible factor 1a (HIF1a) in a human glioblastoma cell line by locked nucleic acid (LNA) antisense oligonucleotides
Høg A, Albæk C, Ørum H, and Kristjansen P |
| 11.30-11.45 |
Functional characterization of the dimerization properties of Mitoxantrone Resistance Associated Protein (MXR/BCRP/ABCP/ABCG2)
Jensen U, Nørregaard L, Gether U, Eriksen J, Litman T |
| |
| 11.45-12.00 |
Pattern of transcription factor mRNAs during in vivo and in vitro differentiation of human neutrophils
Bjerregaard MB, Jurlander J, Borregaard N, Cowland JB |
| 12.00-12.30 |
Uddeling af gårdejer Ingemann Petersen og Hustrus Fond som Dansk Selskab for Cancerforsknings hæderspris.
Foredrag af prismodtageren |
| 12.30-13.15 |
Frokost
|
| 13.15-14.00 |
POSTERS
|
| SESSION III: The plasminogen activation system
Chairmen: Ole William Pedersen, Eva L. Lund |
| 14.00-14.15 |
Studies of the expression and function of uPARAP/Endo180 — a urokinase plasminogen activator receptor-associated protein with putative collagenase and collagen binding properties
Engelholm L, Nielsen BS, Netzel-Arnett S, Solberg H, Lopez JM, Danø K, Behrendt N, and Bugge TH |
| 14.15-14.30 |
Urokinase plasminogen activator and plasminogen activator inhibitor type 1 are prognostic markers in bladder cancer
Offersen BV, Knap MM, Overgaard J |
| 14.30-14.45 |
Dedifferentiation of ovarian cancer is associated with increased tumor tissue content of urokinase plaminogen activator (uPA) and its inhibitor (PAI-1), but decreased content of its receptor (uPAR)
Borgfeldt C, Fernö M, Casslén B |
| 14.45-15.00 |
Plasminogen activator inhibitor-1 (PAI-1) is not required for tumorigenesis, growth, vascularization and metastasis of a transgenic mammary carcinoma
Almholt K, Nielsen BS, Frandsen TL, Brünner N, Danø K, Johnsen M |
| 15.00-15.30 |
POSTERS og kaffe
|
| 15.30-16.30 |
BRISTOL-MYERS SQUIBB LECTURE:
Drug Based Approaches for Targeting Tumour Vasculature
by David J Chaplin
|
| 16.30-16.45 |
Pause med øl/vand
|
| 16.45-16.50 |
Uddeling af pris for bedste foredrag
Bedømmelseskomité: Michael R Horsman og Bodil Norrild |
| 16.50-16.55 |
Uddeling af pris for bedste posterpræsentation
Bedømmelseskomité: Klaus H. Hansen og Anne Katrine Bisgaard |
| 16.55-17.15 |
Tildeling af æresmedlemsskab |
| 18.30 |
Festmiddag
|